Yong Rong Asset Management

Yong Rong Asset Management is a Hong Kong-based investment firm that specializes in global long-biased equity strategies with a concentrated focus on the healthcare, biotechnology, and technology sectors. Founded in 2012 by Peter Xu, the firm utilizes a fundamental, research-driven approach to identify high-growth companies with disruptive potential in the life sciences space. Yong Rong is well-known for being a significant institutional investor in both public markets and late-stage private rounds for leading biopharmaceutical companies, particularly those operating in Greater China and the United States. The firm maintains a high-conviction portfolio that often includes major holdings in innovative oncology, cell therapy, and medical device companies. By leveraging its deep domain expertise in Asian and global healthcare markets, Yong Rong aims to generate long-term value through investments in medical innovation.